Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)

NCT01227265 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

476

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease
Idiopathic Parkinson Disease
Idiopathic Parkinson's Disease

Interventions

DRUG: Preladenant
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC